天弘国证生物医药ETF发起式联接C(011041)份额变动
| 截止日 |
期初份额(份) |
期末份额(份) |
期间申购份额(份) |
期间赎回份额(份) |
| 2025-12-30 |
2,064,356,337.35 |
2,095,385,739.66 |
990,275,088.02 |
959,245,685.71 |
| 2025-09-29 |
2,131,495,027.42 |
2,064,356,337.35 |
1,645,721,920.07 |
1,712,860,610.14 |
| 2025-06-29 |
2,316,219,878.97 |
2,131,495,027.42 |
1,215,476,038.94 |
1,400,200,890.49 |
| 2025-03-30 |
2,359,204,258.74 |
2,316,219,878.97 |
1,323,419,014.04 |
1,366,403,393.81 |
| 2024-12-30 |
2,286,959,822.32 |
2,359,204,258.74 |
2,315,295,092.86 |
2,243,050,656.44 |
| 2024-09-29 |
2,347,263,218.09 |
2,286,959,822.32 |
929,069,242.43 |
989,372,638.20 |
| 2024-06-29 |
2,122,853,420.04 |
2,347,263,218.09 |
966,068,625.05 |
741,658,827.00 |
| 2024-03-30 |
2,081,875,123.25 |
2,122,853,420.04 |
1,053,632,141.22 |
1,012,653,844.43 |
| 2023-12-30 |
2,184,019,754.86 |
2,081,875,123.25 |
995,628,517.14 |
1,097,773,148.75 |
| 2023-09-29 |
2,222,851,437.79 |
2,184,019,754.86 |
1,170,097,211.21 |
1,208,928,894.14 |
| 2023-06-29 |
1,635,176,514.40 |
2,222,851,437.79 |
1,457,190,789.37 |
869,515,865.98 |
| 2023-03-30 |
1,492,035,398.81 |
1,635,176,514.40 |
965,399,290.24 |
822,258,174.65 |
微信公众号
证券之星APP
基本资料
